192 related articles for article (PubMed ID: 23210482)
1. Stabilization and inhibition of protein-protein interactions: the 14-3-3 case study.
Milroy LG; Brunsveld L; Ottmann C
ACS Chem Biol; 2013 Jan; 8(1):27-35. PubMed ID: 23210482
[TBL] [Abstract][Full Text] [Related]
2. Small-Molecule Stabilization of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) Interface.
Bier D; Bartel M; Sies K; Halbach S; Higuchi Y; Haranosono Y; Brummer T; Kato N; Ottmann C
ChemMedChem; 2016 Apr; 11(8):911-8. PubMed ID: 26644359
[TBL] [Abstract][Full Text] [Related]
3. Semisynthesis and biological evaluation of a cotylenin A mimic derived from fusicoccin A.
Inoue T; Higuchi Y; Yoneyama T; Lin B; Nunomura K; Honma Y; Kato N
Bioorg Med Chem Lett; 2018 Feb; 28(4):646-650. PubMed ID: 29398541
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule modulators of 14-3-3 protein-protein interactions.
Ottmann C
Bioorg Med Chem; 2013 Jul; 21(14):4058-62. PubMed ID: 23266179
[TBL] [Abstract][Full Text] [Related]
5. Modulators of 14-3-3 Protein-Protein Interactions.
Stevers LM; Sijbesma E; Botta M; MacKintosh C; Obsil T; Landrieu I; Cau Y; Wilson AJ; Karawajczyk A; Eickhoff J; Davis J; Hann M; O'Mahony G; Doveston RG; Brunsveld L; Ottmann C
J Med Chem; 2018 May; 61(9):3755-3778. PubMed ID: 28968506
[TBL] [Abstract][Full Text] [Related]
6. The phytotoxin fusicoccin, a selective stabilizer of 14-3-3 interactions?
Camoni L; Visconti S; Aducci P
IUBMB Life; 2013 Jun; 65(6):513-7. PubMed ID: 23568668
[TBL] [Abstract][Full Text] [Related]
7. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
Thiel P; Kaiser M; Ottmann C
Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
[TBL] [Abstract][Full Text] [Related]
8. A structural rationale for selective stabilization of anti-tumor interactions of 14-3-3 proteins by cotylenin A.
Ottmann C; Weyand M; Sassa T; Inoue T; Kato N; Wittinghofer A; Oecking C
J Mol Biol; 2009 Mar; 386(4):913-9. PubMed ID: 19244612
[TBL] [Abstract][Full Text] [Related]
9. Strategies to search and design stabilizers of protein-protein interactions: a feasibility study.
Block P; Weskamp N; Wolf A; Klebe G
Proteins; 2007 Jul; 68(1):170-86. PubMed ID: 17393392
[TBL] [Abstract][Full Text] [Related]
10. Small-molecule stabilization of the p53 - 14-3-3 protein-protein interaction.
Doveston RG; Kuusk A; Andrei SA; Leysen S; Cao Q; Castaldi MP; Hendricks A; Brunsveld L; Chen H; Boyd H; Ottmann C
FEBS Lett; 2017 Aug; 591(16):2449-2457. PubMed ID: 28640363
[TBL] [Abstract][Full Text] [Related]
11. New Compound Classes: Protein-Protein Interactions.
Ottmann C
Handb Exp Pharmacol; 2016; 232():125-38. PubMed ID: 26489828
[TBL] [Abstract][Full Text] [Related]
12. Small molecules, peptides and natural products: getting a grip on 14-3-3 protein-protein modulation.
Bartel M; SchÀfer A; Stevers LM; Ottmann C
Future Med Chem; 2014 May; 6(8):903-21. PubMed ID: 24962282
[TBL] [Abstract][Full Text] [Related]
13. An optimised small-molecule stabiliser of the 14-3-3-PMA2 protein-protein interaction.
Richter A; Rose R; Hedberg C; Waldmann H; Ottmann C
Chemistry; 2012 May; 18(21):6520-7. PubMed ID: 22467351
[TBL] [Abstract][Full Text] [Related]
14. An integrative in silico approach for discovering candidates for drug-targetable protein-protein interactions in interactome data.
Sugaya N; Ikeda K; Tashiro T; Takeda S; Otomo J; Ishida Y; Shiratori A; Toyoda A; Noguchi H; Takeda T; Kuhara S; Sakaki Y; Iwayanagi T
BMC Pharmacol; 2007 Aug; 7():10. PubMed ID: 17705877
[TBL] [Abstract][Full Text] [Related]
15. 14-3-3: A Case Study in PPI Modulation.
Ballone A; Centorrino F; Ottmann C
Molecules; 2018 Jun; 23(6):. PubMed ID: 29890630
[TBL] [Abstract][Full Text] [Related]
16. Molecular insight into specific 14-3-3 modulators: Inhibitors and stabilisers of protein-protein interactions of 14-3-3.
Hartman AM; Hirsch AKH
Eur J Med Chem; 2017 Aug; 136():573-584. PubMed ID: 28549334
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of protein-protein interactions in drug discovery.
Andrei SA; Sijbesma E; Hann M; Davis J; O'Mahony G; Perry MWD; Karawajczyk A; Eickhoff J; Brunsveld L; Doveston RG; Milroy LG; Ottmann C
Expert Opin Drug Discov; 2017 Sep; 12(9):925-940. PubMed ID: 28695752
[TBL] [Abstract][Full Text] [Related]
18. Small molecules modulation of 14-3-3 protein-protein interactions.
Mori M; Vignaroli G; Botta M
Drug Discov Today Technol; 2013 Dec; 10(4):e541-7. PubMed ID: 24451646
[TBL] [Abstract][Full Text] [Related]
19. Protein-protein interactions as drug targets.
Skwarczynska M; Ottmann C
Future Med Chem; 2015; 7(16):2195-219. PubMed ID: 26510391
[TBL] [Abstract][Full Text] [Related]
20. Module assembly for designing multivalent mid-sized inhibitors of protein-protein interactions.
Ohkanda J
Chem Rec; 2013 Dec; 13(6):561-75. PubMed ID: 24307545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
